Amlodipine Besylate
NDC 87441-017, Amlodipine besylate, tablet, from Unit Dose Solutions, Inc..
- Product NDC
- 87441-017
- Status
- Listed
- Labeler
- Unit Dose Solutions, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078925
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87441-017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMLODIPINE BESYLATE5 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87441-017-01 | 87441001701 | 30 TABLET in 1 BLISTER PACK (87441-017-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5467eee5-1519-7859-e063-6294a90afed1
Use it
Look up 87441-017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87441-017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87441-017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.